Q4 2020 Holdings
Filed 2021-02-16 | 65 holdings | $33.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $20.7M | 193,223 | 62.0% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $4.3M | 56,003 | 12.9% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $3.4M | 39,226 | 10.1% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $2.8M | 157,403 | 8.5% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $1.2M | 26,722 | 3.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $330.0K | 10,283 | 1.0% |
| Costco Whsl Corp New(COST) | COM | 22160K105 | $317.0K | 841 | 0.9% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $129.0K | 17,260 | 0.4% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $25.6K | 162,633 | 0.1% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $24.0K | 298,721 | 0.1% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $23.9K | 204,138 | 0.1% |
| Viatris Inc(VTRS) | COM | 92556V106 | $19.6K | 1,046,794 | 0.1% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $17.6K | 441,324 | 0.1% |
| Laboratory Corp Amer Hldgs | COM NEW | 50540R409 | $11.0K | 54,105 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $10.3K | 166,077 | 0.0% |
| Lilly ELI & Co(LLY) | COM | 532457108 | $9.4K | 55,521 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $8.4K | 62,235 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $8.3K | 73,906 | 0.0% |
| Anthem Inc(ELV) | COM | 036752103 | $7.5K | 23,374 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $7.2K | 271,974 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $6.9K | 121,409 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $5.9K | 67,384 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $5.2K | 259,283 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $5.0K | 10,423 | 0.0% |
| GW Pharmaceuticals PLC | ADS | 36197T103 | $4.6K | 40,159 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $4.4K | 296,838 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $3.6K | 69,932 | 0.0% |
| Axonics Modulation Technolog(AXNX*) | COM | 05465P101 | $3.2K | 64,378 | 0.0% |
| Lifesci Acquisition II Corp | COM | 53229E103 | $3.2K | 300,000 | 0.0% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $3.1K | 56,402 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $3.0K | 360,697 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.6K | 118,833 | 0.0% |
| Mereo Biopharma Group PLC(MREO) | ADS | 589492107 | $2.6K | 728,710 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $1.7K | 19,832 | 0.0% |
| Oncternal Therapeutics Inc | COM | 68236P107 | $1.4K | 285,714 | 0.0% |
| Cellectar Biosciences Inc | COM PAR | 15117F500 | $1.4K | 658,373 | 0.0% |
| 9 Meters Biopharma Inc | COM | 654405109 | $1.2K | 1,390,821 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $1.1K | 40,910 | 0.0% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $950 | 39,225 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $877 | 49,373 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $688 | 7,178 | 0.0% |
| Procter and Gamble Co(PG) | COM | 742718109 | $447 | 3,210 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $445 | 9,630 | 0.0% |
| Mondelez Intl Inc(MDLZ) | CL A | 609207105 | $386 | 6,608 | 0.0% |
| Colgate Palmolive Co(CL) | COM | 194162103 | $371 | 4,343 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $356 | 62,000 | 0.0% |
| Verizon Communications Inc(VZ) | COM | 92343V104 | $319 | 5,437 | 0.0% |
| Kimberly-Clark Corp(KMB) | COM | 494368103 | $309 | 2,291 | 0.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $297 | 1,695 | 0.0% |
| Merck & Co. Inc(MRK) | COM | 58933Y105 | $297 | 3,631 | 0.0% |